Editor's key points † The effect of high-intensity focused ultrasound was measured in rats with diabetic neuropathy to assess its potential for pain relief. † High-intensity focused ultrasound temporarily blocked compound and sensory action potentials and compound muscle action potentials without damaging nerves. † High-intensity focused ultrasound may have potential for reversibly blocking sensory nerves and providing pain relief.
The increase in temperature induced by ultrasound is one of the mechanisms of inhibition of nerve conduction, and previous experiments have shown that most of these effects occur at 2.7 MHz. 2 3 In patients with polyneuropathy, the compound muscle action potentials (CMAPs) of the peroneal nerve were reduced after 2 min of low-intensity ultrasound exposure and recovered completely within 5 min. 4 Recently, the US Federal Drug Administration approved high-intensity focused ultrasound (HIFU) for the non-invasive treatment of uterine fibroid tumours. 5 6 Furthermore, HIFU has also been applied to suppress nerve conduction and was able to produce a complete and temporary conduction block of bullfrog sciatic nerves in vitro, 7 whilst in rats CMAPs in plantar foot muscles were partly and temporarily blocked by HIFU. 8 However, additional investigations of the effects of HIFU on neuropathic nerves are required. In addition, previous data described the effects on sensory and motor nerves together; thus, the influence of HIFU on sensory nerves alone is uncertain. Diabetic rat models and the evaluation of neuropathic symptoms are well established. 9 10 Behavioural tests (e.g. mechanical allodynia and heat hyperalgesia) have been employed to quantify pain in animals. 11 12 The present study examined the feasibility of blocking nerve conduction, especially the sensory component, using HIFU in neuropathic rats. A streptozotocin (STZ)-induced diabetic rat model was developed, and peripheral neuropathy was confirmed using behavioural tests. Compound action potentials (CAPs) of the sciatic nerve and sensory action potentials (SAPs) of the sural nerve were analysed in vitro before and after HIFU exposure. In addition, the long-term effects of HIFU on the CMAPs of control and neuropathic nerves were examined in vivo.
Methods

Animals
The In vitro experiments Rats (n¼12) were randomly divided into two groups: control rats, which received no STZ injection (n¼6); and diabetic rats, which had received an STZ injection 4 weeks previously (n¼6). Rats were anaesthetized by inhalation of 1.75% isoflurane (Panion & BF Biotech Inc., Taoyuan, Taiwan) in oxygen mixtures delivered via a nose cone. The depth of anaesthesia was assessed by the pedal withdrawal response to a nociceptive stimulus. An incision was made to expose the lateral hamstring muscle, and the connective tissues between the medial and lateral hamstring were loosened to expose the sciatic nerve. The sciatic nerve was dissected from its origin to where the sural nerve ends near the ankle. The nerves were then stored in Ringer solution consisting of 146 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 .6H 2 O, 11 mM D-glucose, and 10 mM HEPES buffer (Amresco LLC, Solon, OH, USA). The length of the dissected nerves was approximately 7 cm. After the surgical procedures, the rats were killed under anaesthesia by CO 2 inhalation. Figure 1 illustrates the experimental configuration. The acrylic nerve platform had three chambers; the central chamber served as the sonication chamber where the nerve was exposed to HIFU, and the left and right chambers were the stimulation and recording chambers, respectively. The electrode wells were filled with Ringer solution to improve electrical contact. The recording chamber had two pairs of electrodes; one pair was placed at the near-knee sciatic nerve, and the other pair was placed at the sural nerve end. Sural nerves are purely sensory nerves, and sciatic nerves are mixed sensory and motor nerves; therefore, the nerve signals from the two sites were SAPs and CAPs, respectively. A needle thermocouple (Omega Engineering, Stamford, CT, USA) was inserted into the central chamber near the nerve to monitor the temperature of the Ringer solution.
Nerve stimulation and recording were accomplished using a Biopac MP36 acquisition system (Biopac Systems, Inc., Goleta, CA, USA). A stimulus with a pulse width of 0.1 ms and supramaximal intensity was applied. The CAPs and SAPs were amplified and filtered between 70 Hz and 3 kHz, and the sampling rate was 50 kHz. Details of the probe and HIFU conditions are provided in the online Supplementary material.
In vivo experiments
Additional rats (n¼18) were randomly divided into the following two groups: control rats, which did not receive STZ (n¼9); and diabetic rats, which were studied 4 weeks after STZ injection (n¼9). Rats were anaesthetized using intraperitoneally injected Zoletil 50 (40 mg kg 21 , Virbac, Carros, France) and xylazine (10 mg kg 21 , Sigma, St. Louis, MO, USA) and placed in ventral recumbency. The depth of anaesthesia was ascertained using the pedal withdrawal response. The sciatic nerves were surgically exposed, and a custom-made nerve fixator was used to ensure the location of the HIFU hot spot on the sciatic nerve. The stimulation site was located at the origin of the sciatic nerve, and CMAPs were recorded from the gastrocnemius muscles. The equipment, stimulus parameters, and sampling rate matched those in the in vitro experiments, and both sciatic nerves were treated. The surgical sites were closed using 4-0 chromic catgut sutures (Unik, Taipei, Taiwan). After surgery, the rats were given ibuprofen in the drinking water (Yung Shin Pharm.,Taichung, Taiwan) for analgesia. The duration of HIFU sonication was increased until either the CAP or CMAP signal was suppressed. Data were acquired once every 2 min during the early phase, every 5 min during the middle phase, and every 10 min in the final phase; total recording time was 2 h. Given that an increase in the temperature of the Ringer solution implies that the liquid (rather than the nerve) was heated by HIFU, CAP and SAP data were not analysed if the temperature increased by .28C in the Ringer solution in the central chamber during sonication. For the in vivo experiments, CMAPs were recorded at 7, 14, and 28 days after the initial HIFU exposures.
Histology
Rats were killed by CO 2 inhalation under anaesthesia after 2 h and 7, 14, and 28 days after HIFU exposure. Sciatic nerves were harvested and fixed in 10% formalin, then stained with hematoxylin and eosin by a technician blinded to the treatment of the rats.
Data analyses
All experimental data are expressed as the median (range). The data were analysed using the Kruskal -Wallis test, with post hoc paired comparisons.
Results
Rats treated with STZ developed polyuria and lost body weight, with significantly increased fasting blood-glucose levels 4 weeks Reversible sensory block by HIFU after STZ injection, indicating diabetes. Diabetic neuropathy manifested as significantly decreased withdrawal latencies and paw withdrawal force. See online Supplementary material for further details.
The CAPs and SAPs of nerves from control rats in vitro were temporarily and incompletely suppressed by 4 s of continuous HIFU at an intensity of 2290 W cm 22 . The CAPs and SAPs were inhibited by 20% 2 min after HIFU exposure, and maximal suppression was seen (approximately 50%) at 10 min, with 30% suppression at 8 min. Full recovery occurred at 40 and 25 min for CAPs and SAPs, respectively ( Fig. 2A) . The CAPs and SAPs of nerves from diabetic rats were inhibited by 12.5 and 5.8%, respectively, 2 min after HIFU exposure, and maximal suppression was only 24% at 20 min and 14% at 10 min, respectively, with full recovery occurring at 120 and 80 min, respectively (Fig. 2B ).
In the in vivo studies, CMAPs in nerves from control rats were suppressed after 7 s HIFU exposure but recovered fully after 8 min (Fig. 3A) . The CMAPs at days 7, 14, and 28 were essentially at baseline amplitude levels (Fig. 3B, diamonds) . The CMAPs after 12 s of HIFU sonication at the same acoustic intensity decreased at 13 s and did not change significantly after 120 min (Fig. 3A) . At 7 days post-HIFU, CMAPs were 69.6 (9.2)% of baseline (Fig. 3B ) and were partly recovered by 14 days and fully recovered by 28 days (Fig. 3B ). When 18 s sonication was used, CMAPs were abruptly reduced, recovered, and gradually decreased again at 120 min (Fig. 3A) . On day 7, CMAPs were approximately 30% of baseline, and they recovered partly by 14 and 28 days (Fig. 3B) .
In nerves from diabetic rats in vivo, after 3 s of HIFU sonication the CMAPs decreased, but they returned to baseline after 30 min (Fig. 4A ) and were completely recovered by day 7 (Fig. 4B ). After 5 s of HIFU sonication at the same intensity, the CMAPs were suppressed at 4 min and recovered by 120 min (Fig. 4A) . The CMAPs at 120 min and 7 days were similar and had returned to baseline levels by day 14 (Fig. 4B ). After 8 s of HIFU sonication at the same intensity, the CMAPs were reduced at 4 min, but increased at 120 min, and gradually increased to 74% of baseline by day 28 (Fig. 4B, triangles) . Figure 5 shows haematoxylin-and eosin-stained longitudinal sections of the HIFU-treated sciatic nerves. In nerves from control rats, the myelin sheath and axon structure were intact on day 1 after HIFU exposure (2290 W cm 22 , 7 s; Fig. 5A ), but disruption of the myelin sheath and increased vacuoles or cavities were seen on day 28 after 18 s of HIFU exposure (Fig. 5B) . Figure 5C shows a nerve from a diabetic rat on day 1 after HIFU exposure (2810 W cm 22 , 3 s). Figure 5D -F are enlarged images of the local regions shown in Figure 5A -C.
Discussion
In vitro, we found that CAPs and SAPs were temporarily and incompletely blocked by HIFU and made a full recovery. Our findings support a previous study showing that the CAPs of normal rat sciatic nerves were partly and temporarily blocked at low exposure (390 W cm 22 , 5 s, 5.7 MHz). 8 The degree of suppression of the HIFU-treated diabetic nerves was less than that of the control nerves, and the duration from suppression to recovery was relatively long.
Only an incomplete block of conduction of the control and diabetic rat nerves was achieved using HIFU, most probably attributable to the different fibre compositions of the nerve. The rat sciatic nerve at the mid-thigh is typically composed of approximately 27 000 axons, 6% of which are myelinated motor axons, 23 and 48% of which are myelinated and unmyelinated sensory axons, respectively, and 23% of which are unmyelinated sympathetic axons. 14 The rat sural nerve generally contains 1100 myelinated and 2800 unmyelinated afferent axons and 1500 unmyelinated sympathetic axons. The differential acoustic properties of these axons can affect the delivered HIFU dose. It has been shown using the brain of cats that acoustic energy can be absorbed primarily by lipid and protein. 15 Given that myelin is primarily fat and absorbs sound very efficiently, myelinated nerves will absorb more of the delivered HIFU than unmyelinated nerves. In addition, thermal conduction can affect the temperature distribution, and it is therefore difficult to block nerve conduction completely without causing damage. The acoustic and thermal properties might explain the variations observed between the nerves of control and diabetic rats. Ultrasound studies have verified that the peripheral nerves of patients with diabetic neuropathy are larger than nerves from non-diabetic patients or diabetic patients without neuropathy. 16 17 However, there is little information on the ultrasound absorption and thermal conduction properties of normal nerves compared with diabetic nerves, and differences in one or both of these may explain our findings, 18 19 because myelin structure, perineurium thickness, connective tissue content, and loss of unmyelinated axons may result in variations in absorption and conduction. 20 -22 In addition, the nerves in the diabetic rats may have a higher threshold and therefore a weaker response to ultrasound. The fibre composition of the sural nerve is a bimodal distribution of A and C fibres. Large A fibres dominated the SAPs recorded in our experiments. In fact, analgesia is highly related to nociceptor-like C fibres. In the cat, the smallest C fibres in the saphenous nerve are most sensitive to ultrasound, and the largest Aa fibres are the most resistant. 23 We hypothesize that the HIFU dose used to suppress the conduction of A fibres might synchronously block the conduction of C fibres because the HIFU-induced temperature increased in C fibres was higher than that in A fibres. As a result, the SAP suppression observed in our experiments suggests that the C fibres were also blocked. The degree of block and the safety of the C fibres treated using HIFU require additional study.
In the present in vivo study, the control rat nerves were blocked by .30% immediately after HIFU treatment and recovered fully after 8 min. Reversible sensory block by HIFU BJA treated control nerves continued to display an organized myelin sheath and axon structure. The follow-up conduction measurements on days 7, 14, and 28 also showed that the CMAPs approximated 100% of baseline. Therefore, an appropriate HIFU dose can suppress conduction without an appreciably adverse effect on normal rat nerves. However, our data suggest that the control rat nerves could be damaged with increased HIFU doses, and histological examination showed that a relatively high HIFU dose was able to disrupt the myelin sheath and increase the number of vacuoles or cavities in the treated nerve. A high HIFU dose might simultaneously induce thermal and non-thermal effects on the nerve; 24 high temperatures cause fibre necrosis, whilst cavitation directly bombs the fibres, both of which reflect granular spaces. Furthermore, the fibres deform into a wave-like shape and may even be disrupted because of the stretch of strong acoustic forces. Incomplete and temporary conduction block of the nerves from diabetic rats in vivo was also observed, with the blocking effect occurring instantly after HIFU treatment. The follow-up CMAPs at baseline and the intact morphology seen on histogical examination showed that the temporary conduction block was not harmful at an appropriate HIFU dose. The suppression of nerves from diabetic rats was weak compared with control nerves and concurs with results of the in vitro study. However, the degree of suppression in vivo was smaller than that seen in vitro. This may be explained by intercellular fluid and blood flow in vivo decreasing the absorption of the HIFU and accelerating the dissipation of the HIFU-induced heat. Moreover, blood supply might speed recovery of conduction, so that the recovery time of the nerves in vivo is shorter than that seen in vitro.
In mild nerve injuries, axonal degeneration is not present and sensory recovery is complete over a period of hours to several days. 25 For more severe injuries, the time course of sensory recovery usually takes several months if it occurs at all. In addition, peripheral nerve fibres regenerate more completely when the endoneurial tubes and Schwann cell basal lamina are intact following crushing vs cut injuries. 26 As a result, we hypothesize that the HIFU caused mild but reversible nerve injuries seen as decreased CMAPs after HIFU treatment, with return to baseline over time. For more severe nerve injuries, the CMAPs only recovered partly even after 28 days, and histological examination also showed that the fibres were disrupted in certain regions of the nerve. Previous studies have demonstrated the various parameters that cause thermal injury to neural tissue in different animal models. 27 -30 Table 1s in the online Supplementary material. In practice and for safety reasons, it is necessary to monitor the temperature of HIFU-treated nerves in real time. We did not measure the temperature of the nerve directly because of the technical difficulty involved. Elsewhere, magnetic resonance imaging thermometry is a useful tool to detect bodily temperature non-invasively. 31 32 However, the average diameter of the rat sciatic nerve is only 1.0 mm, and the resolution of current magnetic resonance imaging thermometry is insufficient for this application. We found no white lesions in the surrounding muscle tissue after the nerve was heated by HIFU with the dose used in the present study. Although temperature elevation is one of the causes of nerve conduction block, 2 4 7 33 the mechanism responsible for the reversible inhibition of CAPs remains unclear. The HIFU-induced analgesic effects on normal and diabetic nerves lasted only 8 and 30 min, respectively, based on our in vivo investigations, which may limit furture clinical use, although repeating the HIFU exposure might extend the analgesia. In addition, the severity of pain may not be proportional to the magnitude of SAP. The pathological decrease of sensory fibres in diabetes mellitus results in hypoaesthesia, but accompanied by allodynia and dysaesthesia. This may reflect the fact that pain in diabetes mellitus is the consequence of peripheral and central interactions. The temporary reduction of SAP by HIFU represents a reduction of peripheral inputs in surviving fibres, similar to the effects of local anaesthetics; therefore, it should be ineffective for blocking the central contribution, but it might be used as a tool to estimate the relative contribution of peripheral and central components.
Blocking nerve conduction in nociceptors will be likely to reduce the experience of pain in acute conditions, but in the context of chronic pain, where central sensitization plays a role, this approach may not be effective. In addition, a larger HIFU dose would be required to create the effect observed in our study because the tissue in the acoustic path will attenuate the energy and the surrounding tissue will absorb heat.
To the best of our knowledge, the present study is the first to investigate the use of HIFU for nerve conduction blocks in diabetic nerves and lays the foundation for the potential use of HIFU as a pain relief tool in patients with neuropathy. However, further studies are needed, because mixed fibres are more sensitive to suppression than sensory fibres, and thus, some weakness is expected to accompany pain relief. It is important to determine the proper range of parameters so that the side-effects of HIFU are acceptable. In addition, diabetic nerves were more resistant than normal nerves to the blocking effects of HIFU, thereby demanding the use of stronger HIFU treatments to achieve equivalent effects, but this carries a greater risk of nerve damage. Thus, additional studies are needed to investigate the safety of the dose of HIFU required to achieve the desired suppression in diabetic nerves. Although we showed indirect evidence for the safety of the HIFU blocking technique in rat nerves, behavioural pain assessments of rats treated with HIFU must be performed.
We conclude that the reversible conduction block of normal and diabetic rat sciatic nerves can be achieved using HIFU treatment. Our studies demonstrated that a blocking effect occurred immediately post-HIFU treatment and lasted between 10 and 30 min. We also found that provided the HIFU dose was kept within certain parameters, the technique appeared not to cause nerve damage.
